(2) demonstrated that eccDNA (especially ecDNA, megabase-scale subtypes) was prevalent across cancers such as glioblastoma and colorectal cancer, often harboring oncogenes (e.g., MYC and EGFR) to drive aggressive phenotypes. The gene discussed is MYC; the disease is glioblastoma.